Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

• A. T. Cohen,

  Affiliation Guy’s and St Thomas’ Hospitals, King’s College, London, United Kingdom

  ⨯
• M. Hamilton,

  Affiliation BMS, Princeton, United States of America

  ⨯
• A. Bird,

  Affiliation Pfizer, Walton Oaks, United Kingdom

  ⨯
• S. A. Mitchell,

  Affiliation Abacus International, Bicester, United Kingdom

  ⨯
• S. Li,

  Affiliation BMS, Princeton, United States of America

  ⨯
• R. Horblyuk,

  Affiliation Pfizer, New York, United States of America

  ⨯
• S. Batson

  * E-mail: sbatson@teamdrg.com

  Affiliation Abacus International, Bicester, United Kingdom

  ⨯